Pulmonary and systemic effects of PM2.5 exposure during Southeast Asia deployment
Official title: CMA:Pulmonary and Systemic Effects of Deployment Related Particulate Matter Exposures
Funded at Minneapolis VA Medical Center · NIH-11264807 · Data updated 2026-11-12
This project will follow Veterans exposed to fine airborne particles during Southeast Asia deployment to learn how those exposures relate to lung health and overall body function.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Minneapolis VA Medical Center NIH-funded |
| Lab location | 1 site (Minneapolis, United States) |
| Project start | January 1, 2020 |
| Project end | March 31, 2028 |
| Funding year | 2027 |
| NIH project number | 5I01BX004633-07 |
| Project ID | NIH-11264807 on NIH RePORTER |
Who could benefit from this research
✓Could help
Veterans with known Southeast Asia deployment exposure, especially those with chronic cough, wheeze, or dyspnea and minimal smoking history.
✕Less likely to help
Veterans without exposure history or without respiratory symptoms and with significant smoking history may have limited relevance for this study.
What this research studies
Researchers will study a cohort of Veterans from SHADE to see how past PM2.5 exposure is linked to lung function and respiratory symptoms. They will recruit 280 SHADE participants with and without respiratory symptoms, focusing on non- or former-smokers with light smoking history, across four sites. The work aims to identify biophysical and clinical effects of PM exposure on pulmonary and systemic health, in relation to symptom history. Findings could illuminate early lung changes and systemic impacts from deployment-related air pollution.
Why it matters
Potential benefit: If successful, the project could improve understanding of how PM2.5 exposure affects lung and systemic health in Veterans, guiding better screening and care.
How similar studies have gone: Previous SHADE cohorts have linked PM exposure to respiratory outcomes, and this study builds on that foundation with a targeted sub-cohort.
Where this research is happening
-
Minneapolis VA Medical Center
Minneapolis, United States Active
Researchers
- Principal investigator: Wendt, Chris H — Minneapolis VA Medical Center
- Study coordinator: Wendt, Chris H
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.